
Abiomed ABMD
Quarterly report 2022-Q3
added 11-03-2022
Abiomed Interest Expense 2011-2026 | ABMD
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Abiomed
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 58.7 M | 7.61 M | 30.4 M | -388 K | -349 K | 339 K | -97 K | 49 K | 326 K | 9 K | -143 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 58.7 M | -388 K | 8.76 M |
Quarterly Interest Expense Abiomed
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 80.7 M | 84.5 M | - | -7.58 M | 6.84 M | 46.8 M | - | 7.94 M | 7.94 M | 9.76 M | 24.6 M | 23.7 M | 23.7 M | -45.8 M | 39.4 M | -20 K | -20 K | -158 K | - | -81 K | -23 K | 79 K | - | -34 K | -225 K | -191 K | - | -29 K | 111 K | 140 K | - | -10 K | -38 K | -39 K | - | 20 K | 5 K | -15 K | - | 324 K | 311 K | -13 K | - | 39 K | 24 K | -15 K | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 84.5 M | -45.8 M | 8.18 M |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Medtronic PLC
MDT
|
402 M | $ 87.12 | 0.62 % | $ 112 B | ||
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Second Sight Medical Products
EYES
|
1.19 M | - | -0.97 % | $ 54.4 M | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 2.13 | 6.22 % | $ 1.29 M | ||
|
Orthofix Medical
OFIX
|
8.11 M | $ 11.97 | 2.13 % | $ 474 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Inogen
INGN
|
2.44 M | $ 6.3 | -0.4 % | $ 168 M | ||
|
IRadimed Corporation
IRMD
|
164 K | $ 102.82 | 1.83 % | $ 1.31 B | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
LENSAR
LNSR
|
660 K | $ 5.66 | 1.8 % | $ 65.2 M | ||
|
Insulet Corporation
PODD
|
14.3 M | $ 225.87 | 0.16 % | $ 15.9 B | ||
|
AxoGen
AXGN
|
167 K | $ 33.16 | 1.69 % | $ 1.53 B | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 36.85 | 0.72 % | $ 1.14 B | ||
|
AVITA Medical
RCEL
|
5 M | $ 4.04 | 5.21 % | $ 113 M | ||
|
NanoVibronix
NAOV
|
135 K | - | - | $ 1.08 M | ||
|
Electromed
ELMD
|
78 K | $ 24.7 | 0.2 % | $ 209 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Aethlon Medical
AEMD
|
10.1 K | $ 2.25 | 3.94 % | $ 3.51 M | ||
|
InspireMD
NSPR
|
200 K | $ 1.79 | 1.13 % | $ 115 M | ||
|
Profound Medical Corp.
PROF
|
146 K | $ 5.23 | 1.55 % | $ 180 M | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Sintx Technologies
SINT
|
31 K | $ 2.62 | 1.95 % | $ 7.27 M | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 11.61 | 1.13 % | $ 1.57 B | ||
|
Myomo
MYO
|
-668 K | $ 0.72 | 3.24 % | $ 30.1 M | ||
|
Smith & Nephew plc
SNN
|
145 M | $ 32.46 | 0.92 % | $ 23.8 B | ||
|
Penumbra
PEN
|
893 K | $ 335.79 | 0.46 % | $ 13.1 B | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.69 | -5.63 % | $ 138 M | ||
|
Sensus Healthcare
SRTS
|
683 K | $ 3.96 | - | $ 64.7 M | ||
|
Quanterix Corporation
QTRX
|
157 K | $ 3.95 | 3.4 % | $ 168 M | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 16.04 | 0.82 % | $ 376 M | ||
|
Outset Medical
OM
|
14 M | $ 3.56 | 0.85 % | $ 54.2 K |